bpc-157 clinical trial multiple sclerosis Canada Research Guide 2026: Sourcing, and Compliance Ocrelizumab versus Placebo in Primary

Have you ever had pain in your feet, ankles, knees, hips or back

When semaglutide, a GLP-1 receptor, swept through American culture around 2022 and 2023, it did something no wellness trend had done before at that scale: it normalized self-injection for millions of people who had never thought of themselves as the kind of person who injects anything

NAD+ levels decline with age, and supplementation is believed to enhance energy levels, improve cognitive function, and slow the aging process

Pollution and climate change, chemical compounds commonly used in industry and households, ecosystem changes, unhealthy diet, and stimulants, mainly alcohol, tobacco and e-cigarettes, may disrupt the epithelial barriers of the skin and mucosal surfaces